Enzalutamide in Metastatic or Advanced Non-resectable Granulosa Cell Ovarian Tumors: GREKO III Study

Condition:   Ovarian Cancer Intervention:   Drug: Enzalutamide 40 MG Sponsor:   Grupo Español de Tumores Huérfanos e Infrecuentes Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials